Cell Journal Citation Rate 2026
0092-8674
eISSN 1097-4172
Elsevier
US
Q1 Quartile Hybrid Top Tier Verified Publisher
About Cell
Cell (C) is a peer-reviewed academic journal covering Cell Biology and Genetics, published by Elsevier in US and in circulation since 1974. It is catalogued under ISSN 0092-8674 (electronic ISSN 1097-4172).
Authors typically receive a first decision in around 94 days.
Cell Citation Rate 2026 — In Context
Cell has a 2024 2-Year Citation Rate (OpenAlex) of 64.50, placing it in the Q1 quartile within the Cell Biology research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not a OpenAlex Journal Impact Factor.
Cell operates a hybrid open-access model — authors may pay an APC of approximately $9900 USD to make individual articles open access, while the rest remain subscription-only. Average submission-to-decision turnaround is approximately 94 days.
Researchers looking to publish in Cell should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Cell against similar journals in the field, use our journal comparison tool.
Submission Tips for Cell
- Be prepared for a longer review cycle — decisions typically take around 94 days.
- Budget $9900 for the Article Processing Charge. Check if your institution or funder covers OA fees.
- This journal covers Cell Biology, Genetics, Life Sciences. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Cell Compares
Compared against 9 journals in the same research areas.
| ISSN (Print) | 0092-8674 |
|---|---|
| ISSN (Online) | 1097-4172 |
| Publisher | Elsevier |
| Country | United States |
| Established | 1974 |
| APC / Cost | $9900 USD |
| Review Speed | ~94 days to first decision |
In-depth profile & metrics
Cell is published by Elsevier, based in United States and in publication since 1974. It runs on a subscription or hybrid model with an article-processing charge of USD 9900.
In our subject taxonomy, Cell is classified under Cell Biology, Genetics and Life Sciences.
For prospective authors, Cell returns a first decision in about 94 days (longer for its field).
Its citation rate has risen over the last 5 years, from 36.200 (2019) to 64.500 (2024).
Research Areas
Continue on JournalsHub
Put what you just read into practice with these free tools.
Frequently Asked Questions about Cell
Live Indexing Status
Updated March 2026Track real-time indexing metrics to ensure this journal meets your academic requirements.
Citation Rate
Historical Trend
The impact factor has grown by 78% over the last 5 years (from 36.200 to 64.500), indicating rising influence and citation activity in its field.
Citation Rate by Year
| Year | Value | Source |
|---|---|---|
| 2024 | 64.500 | 2-Year Mean Citedness (OpenAlex) |
| 2023 | 61.275 | 2-Year Mean Citedness (OpenAlex) |
| 2022 | 66.800 | 2-Year Mean Citedness (OpenAlex) |
| 2021 | 41.500 | 2-Year Mean Citedness (OpenAlex) |
| 2020 | 38.600 | 2-Year Mean Citedness (OpenAlex) |
Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.
Journal Metrics
Research Highlights
Recently published high-impact papers in this journal:
-
Is asciminib an effective tyrosine kinase inhibitor for chronic myeloid leukemia patients with tyrosine kinase inhibitor resistance?
Musab M. A. Omar, Majed A Alanazi, Denise E. Jackson • 2026
-
The Double-Edged Sword Effect of the Fibrinolytic System in Alzheimer’s Disease
Mingqing Tang, Meimei Liang, Xianying Zhang • 2026
-
Hallmarks of the pre-disease state: prevention and control of the pre-disease state, a tipping point between health and disease
Pei Chen, Tong Wang, Rui Liu • 2026
-
Sugen kinase 495 promotes the proliferation, migration and invasion of lung squamous cell carcinoma cells by targeting Foxo1 transcription factor
Yuanmei Lou, Jun Chen, Yangpeng Tang • 2026
-
MYBPC3 (c.194 C > T) mutation-mediated RyR2 dysfunction contributes to pathogenic phenotypes of DCM revealed by HiPSC modeling
Manting Xie, Bingbing Xie, Liang Huang • 2026
Compare Journals
Compare Cell against similar publications in its field:
Related Journals in Your Field
-
Nature Nature Portfolio IF 69.50
-
Science American Association for the Advancement of Science IF 63.70
-
Proceedings of the National Academy of Sciences National Academy of Sciences IF 54.05
-
Nature Communications Nature Portfolio IF 17.70
-
eLife eLife Sciences Publications Ltd IF 8.70
Explore More Journals
Metadata
Last updated: Mar 20, 2026
Updated by: system
Get weekly updates for Cell Biology journals
Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.